Related Experiment Video
Updated: Jan 16, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
An innovative model for pharmacogenomics critical results identification and intervention
Ryley Uber1,2, Vanessa A Hayduk3, Alison Flango4
1Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, USA. ruber@geisinger.edu.
None:
Pharmacogenomics (PGx) test results are returned variably across healthcare settings, which can lead to challenges particularly when results require immediate intervention to avoid adverse consequences. While several return of result models exist in literature, a standard-of-care has not been established. We propose a model to safely return PGx results in the context of scaled and sustained PGx testing: an institutional protocol to integrate new PGx results into patient care.
More Related Videos
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Drug Discovery: Overview

